https://www.selleckchem.com/pr....oducts/rgd-arg-gly-a
Background Actissist is a smartphone app designed to deliver an intervention grounded in cognitive behavior therapy for early psychosis. Actissist was developed by a multidisciplinary team of academics, clinicians, experts by experience and software engineers. Actissist has been tested in two trials, the first a proof-of-concept trial where Actissist was safe, acceptable and feasible, the second, a powered randomized controlled trial. Objective This article describes how our multidisciplinary team designed and developed
Gefällt mir
Kommentar
Teilen
